Lurasidone is a generic prescription tablet used to treat schizophrenia and depression caused by bipolar disorder. Lurasidone’s cost may depend on factors such as your dosage, whether you have health ...
Antidepressant use in bipolar depression remains contentious because efficacy is inconsistent and exposure can trigger manic switching, particularly in patients without prior documented mania.
Lurasidone is a generic oral tablet prescribed for schizophrenia and bipolar depression in adults and some children. It’s available as the brand-name drug Latuda. The cost of lurasidone with and ...
If you have schizophrenia or bipolar I disorder, your doctor may prescribe a daily pill called lurasidone (Latuda). It’s an atypical or second-generation antipsychotic (SGA). Like other SGAs, ...
December 15, 2009 (Hollywood, Florida) — Lurasidone, a serotonin dopamine antagonist, effectively treats symptoms of schizophrenia with few adverse metabolic effects, including weight gain, according ...
WASHINGTON — Lurasidone (Latuda, Sunovion Pharmaceuticals Inc), which received US Food and Drug Administration approval last month as the first single-agent formulation indicated for bipolar ...
Discover comprehensive details about Lurasidone, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...
Lurasidone was associated with medium to large treatment effect sizes in adult patients with schizophrenia who presented with prominent positive symptoms. SAN ANTONIO, TX—Lurasidone was associated ...
FORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...
Review the side-effects of Lurasidone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
female patient hospital Patients with bipolar disorder who received lurasidone monotherapy had "significantly lower odds of mental health-related hospitalizations" when compared with olanzapine, ...
In June 2013, the FDA expanded its indication for the antipsychotic lurasidone, marketed as Latuda, for use in bipolar disorder, either as a monotherapy or in combination with lithium or valproate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results